|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Tracon Pharmaceuticals, Inc. (TCON) |
|
|
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,680,000 |
Market
Cap: |
3.49(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1322 - $0.67 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,418,993 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,892,637 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
30 |
Total Shares Sold |
0 |
0 |
4,764,008 |
4,765,667 |
Total Sell Value |
$0 |
$0 |
$1,401,571 |
$1,403,938 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
3 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Theuer Charles |
President and CEO |
|
2022-04-08 |
4 |
B |
$2.50 |
$5,000 |
D/D |
2,000 |
226,518 |
2.81 |
-17% |
|
Theuer Charles |
President and CEO |
|
2022-03-30 |
4 |
B |
$2.70 |
$10,800 |
D/D |
4,000 |
224,518 |
2.81 |
-29% |
|
Brown Scott B. |
Chief Financial Officer |
|
2022-03-29 |
4 |
B |
$2.82 |
$2,820 |
D/D |
1,000 |
8,628 |
2.66 |
-31% |
|
Theuer Charles |
President and CEO |
|
2022-03-21 |
4 |
B |
$2.45 |
$2,940 |
D/D |
1,200 |
220,518 |
2.73 |
-31% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-03-16 |
4 |
B |
$2.20 |
$4,917 |
I/I |
2,235 |
2,837,735 |
1.42 |
-28% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-01-28 |
4 |
B |
$2.20 |
$1,100 |
I/I |
500 |
2,820,500 |
1.42 |
-35% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-01-24 |
4 |
B |
$2.05 |
$35,603 |
I/I |
17,363 |
317,363 |
1.5 |
-30% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-01-21 |
4 |
B |
$2.19 |
$76,811 |
I/I |
35,000 |
315,000 |
1.5 |
-23% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-01-20 |
4 |
B |
$2.25 |
$47,952 |
I/I |
21,312 |
310,000 |
1.5 |
-24% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-01-19 |
4 |
B |
$2.24 |
$53,080 |
I/I |
23,688 |
308,688 |
1.5 |
-18% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-29 |
4 |
B |
$2.51 |
$131,362 |
I/I |
52,325 |
305,000 |
1.5 |
-32% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-28 |
4 |
B |
$2.63 |
$52,950 |
I/I |
20,125 |
285,000 |
1.5 |
-20% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-27 |
4 |
B |
$2.92 |
$255,103 |
I/I |
87,325 |
265,000 |
1.5 |
-31% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-15 |
4 |
B |
$2.43 |
$53,287 |
I/I |
21,964 |
252,675 |
1.5 |
-19% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-14 |
4 |
B |
$2.53 |
$106,344 |
I/I |
42,000 |
250,711 |
1.5 |
-15% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-13 |
4 |
B |
$2.64 |
$40,154 |
I/I |
15,204 |
243,711 |
1.5 |
-17% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-06 |
4 |
B |
$2.26 |
$51,474 |
I/I |
22,733 |
242,507 |
1.5 |
3% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-03 |
4 |
B |
$2.30 |
$204,911 |
I/I |
89,274 |
239,774 |
1.5 |
12% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-02 |
4 |
B |
$2.35 |
$24,660 |
I/I |
10,500 |
230,500 |
1.5 |
12% |
|
Opaleye Management Inc. |
10% Owner |
|
2021-12-01 |
4 |
B |
$2.40 |
$120,160 |
I/I |
50,000 |
230,000 |
1.5 |
7% |
|
Theuer Charles |
President and CEO |
|
2021-11-05 |
4 |
B |
$3.41 |
$13,655 |
D/D |
4,000 |
215,137 |
2.81 |
-26% |
|
Theuer Charles |
President and CEO |
|
2021-08-16 |
4 |
B |
$3.56 |
$10,680 |
D/D |
3,000 |
207,732 |
2.81 |
-16% |
|
Brown Scott B. |
Chief Financial Officer |
|
2021-08-13 |
4 |
B |
$3.69 |
$3,695 |
D/D |
1,000 |
7,628 |
2.66 |
2% |
|
Pelletier Saundra L |
Director |
|
2021-07-26 |
4 |
B |
$3.82 |
$25,002 |
D/D |
6,545 |
12,045 |
2.39 |
-38% |
|
Larue William R |
Director |
|
2021-07-26 |
4 |
B |
$3.82 |
$25,002 |
D/D |
6,545 |
7,883 |
2.39 |
-38% |
|
241 Records found
|
|
Page 3 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|